Depression symptom profiles and long-term response to cognitive behavioral therapy plus contingency management for smoking cessation

González-Roz A. ; Secades-Villa R. ; García-Fernández G. ; Martínez-Loredo V. (Universidad de Zaragoza) ; Alonso-Pérez F.

Resumen: Background: Depression is heterogeneous in nature and using diagnostic categories limits insight into understanding psychopathology and its impact on treatment efficacy. This secondary analysis sought to: 1) identify distinct subpopulations of cigarette users with depression, and 2) examine their response to cognitive-behavioral treatment (CBT) + contingency management (CM) for smoking cessation at one year. Method: The sample comprised 238 (74 % females) adults who smoke receiving CBT only or CBT + CM. A latent class analysis was conducted on baseline depressive symptoms measured using the Beck Depression Inventory-II. Generalized estimating equations assessed the main and interactive effects of class, time, treatment, and sex on smoking abstinence. Results: Three distinct classes were identified: C1 (n= 76/238), characterized by mild depression, loss of energy, pessimism, and criticism, C2 (n= 100/238) presenting moderate severity and decreased appetite, and C3 (n= 62/238) showing severe depression, increased appetite, and feelings of punishment. There was a significant cluster × treatment interaction, which indicated additive effects of CM over CBT alone for Class 1 and 2. Persons in Class 1 and 2 were 3.60 [95 % CI: 1.62, 7.97] and 2.65 [95 % CI: 1.19, 5.91] times more likely to be abstinent if CBT + CM was delivered rather than CBT only. No differential sex effects were observed on treatment response according to cluster. Conclusions: Profiling depression symptom subtypes of cigarette users may be more informative to improve CM treatment response than merely focusing on total scores.

Idioma: Inglés

DOI: 10.1016/j.drugalcdep.2021.108808

Año: 2021

Publicado en: Drug and Alcohol Dependence 225 (2021), 108808 [7 pp.]
ISSN: 0376-8716

Factor impacto JCR: 4.852 (2021)

Categ. JCR: SUBSTANCE ABUSE rank: 8 / 37 = 0.216 (2021) - Q1 - T1
Categ. JCR: PSYCHIATRY rank: 44 / 143 = 0.308 (2021) - Q2 - T1
Categ. JCR: PSYCHIATRY rank: 61 / 155 = 0.394 (2021) - Q2 - T2
Categ. JCR: SUBSTANCE ABUSE rank: 6 / 21 = 0.286 (2021) - Q2 - T1

Factor impacto CITESCORE: 6.1 - Medicine (Q1) - Pharmacology, Toxicology and Pharmaceutics (Q2)

Factor impacto SCIMAGO: 1.438 - Pharmacology (Q1) - Toxicology (Q1) - Pharmacology (medical) (Q1)

Financiación: info:eu-repo/grantAgreement/ES/MICINN/BES-2016-076663
Financiación: info:eu-repo/grantAgreement/ES/MICINN/PSI2015-64371-P

Tipo y forma: Artículo (Versión definitiva)

Área (Departamento): Área Person.Eval.Trat.Psicoló. (Dpto. Psicología y Sociología)